FDA Webview
X

Free FDA Notices

Comments Sought on Iontophoresis Device Reclassification

11/04/2004
Federal Register Notice: FDA seeks information and comments on the agency’s intent to reclassify iontophoresis devices currently in Class 3 (premarket approval) into Class 2 (special controls). An iontophoresis device is intended to use a direct current to introduce ions of soluble salts or other drugs into the body and induce sweating for diagnostic or other uses. To view this notice, click here.

LATEST NEWS